Introduction

SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDT) are being used globally to test suspect COVID-19 cases in contexts where PCR diagnostic may not be available, often at subnational level.

COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

Individual factors can contribute to SARS-CoV-2 transmission

● People infected with SARS-CoV-2 can transmit virus with or without symptoms

● Most infected people transmit the virus around 2 days before they develop symptoms and up to 9-10 days after symptom onset

● People who develop severe disease can be infectious for longer

● Immunocompromised people can shed the virus for months

● Symptomatic persons infected with SARS-CoV-2 are 3 to 18 times more likely to transmit the virus than asymptomatic persons.

Detection

The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in saliva.

Specimen

Saliva

Limit of Detection (LoD)

2019 Novel Coronavirus: 74.8 TCID₅₀/mL

Accuracy

Positive Percent Agreement: 96.5%

Negative Percent Agreement:97.8%

Overall Percent Agreement: 97.2%

Time to Results

Read results at 15minutes and no more than 30 minutes.

Kit Storage Conditions

2~30°C.

Contents

Ordering Information